2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O13] Oral Session 13　Lung Cancer / Thoracic Cancer 3（Rare gene alterations）
【E】

Sat. Feb 19, 2022 8:20 AM - 9:50 AM Room 1 (Main Hall, 1F, Kyoto International Conference Center)

Chair：Satoshi Oizumi（Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center），Haruyasu Murakami（Chemotherapy Center/Division of Thoracic Oncology, Shizuoka Cancer Center）
Discussant：Takehito Shukuya（Department of Respiratory Medicine, Juntendo University）

[O13-2] Efficacy of sotorasib in KRAS p.G12C-mutated NSCLC with stable brain metastases: a post-hoc analysis of CodeBreaK 100

○Toyozawa Ryo1, Suresh S. Ramalingam2, Ferdinandos Skoulidis3, Ramaswamy Govindan4, Vamsidhar Velcheti5, Bob T. Li6, Benjamin Besse7, Grace K. Dy8, Dong-Wan Kim9, Martin Schuler10, Mark Vincent11, Frederick Wilson12, Joseph Park13, Juan E. Gutierrez14, Qui Tran13, Simon P. Jones13, Juergen Wolf15 (1.Division of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 2.Winship Cancer Institute, Emory University School of Medicine, 3.University of Texas M.D. Anderson Cancer Center, 4.Alvin J. Siteman Cancer Center, Washington University School of Medicine, 5.Perlmutter Cancer Center, NYU Langone, 6.Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, 7.Gustave Roussy Institute, 8.Roswell Park Cancer Institute, 9.Seoul National University Hospital, 10.West German Cancer Center, University Hospital Essen, 11.London Regional Cancer Program, 12.Yale School of Medicine, 13.Amgen Inc, 14.Cedimed-Quiron Salud, 15.University Hospital Cologne)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password